Antibody Response Against SARS-CoV-2 in Dialysis Patients During COVID-19

Region MidtJylland Denmark300 enrolled

Overview

Determination of IgM and IgG antibodies against SARS-CoV-2 in dialysis patients by continous monitoring in the period from March 2020 to december 2020

Blood samples are collected every 14 days

Study Type

OBSERVATIONAL

Enrollment

300

Conditions

COVID Terminal Renal Insufficiency

Eligibility

Sex: ALLMin age: 18 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Dialysis Exclusion Criteria: * Not willing to give consent

Locations (1)

Godstrup Hospital

Herning, Denmark

RECRUITING

Outcomes

Primary Outcomes

AAntibody response

IgM and IgG against SARS-CoV-2

Time frame: 1 year

Central Contacts

Frank Mose, MD

CONTACT

+4528531257 frchri@rm.dk

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.